Medical Foods Global Market Report 2022

“Medical Foods Global Market Report 2022” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global medical foods market.

This report focuses on medical foods market which is experiencing strong growth. The report gives a guide to the medical foods market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.

• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.

• Create regional and country strategies on the basis of local data and analysis.

• Identify growth segments for investment.

• Outperform competitors using forecast data and the drivers and trends shaping the market.

• Understand customers based on the latest market research findings.

• Benchmark performance against key competitors.

• Utilize the relationships between key data sets for superior strategizing.

• Suitable for supporting your internal and external presentations with reliable high quality data and analysis

• Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the medical foods? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Medical Foods market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider medical foods market, and compares it with other markets.

• The market characteristics section of the report defines and explains the market.

• The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.

• Market segmentations break down market into sub markets.

• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.

• Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

• The medical foods market section of the report gives context. It compares the medical foods market with other segments of the medical foods market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, medical foods indicators comparison.

Scope

Markets Covered:

• 1) By Type: Pills; Powder; Others

• 2) By Application: Alzheimers Disease; Diabetic Neuropathy; Nutritional Deficiency; ADHD; Others

• 3) By Sales Channel : Retail Sales; Online Sales; Institutional Sales

• Companies Mentioned: Nestle; Mead Johnson & Company LLC; Fresenius Kabi AG; Danone; Primus Pharmaceuticals Inc.

• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

• Time series: Five years historic and ten years forecast.

• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Executive Summary

Major players in the medical foods market are: Nestle, Mead Johnson & Company LLC, Fresenius Kabi AG, Danone, Primus Pharmaceuticals Inc, Abbott Laboratories, Metagenics Inc, Targeted Medical Pharma Inc, Medtrition Inc, Cerecin Inc, Entera Health Inc., Vaya Pharma Inc., Physician Therapeutics LLC, Alfasigma spA, and MicroBiome Therapeutics LLC.

The global medical foods market is expected to grow from $18.36 billion in 2021 to $19.38 billion in 2022 at a compound annual growth rate (CAGR) of 5.59%. The medical foods market is expected to grow to $24.11 billion in 2026 at a compound annual growth rate (CAGR) of 5.61%.

The medical foods market consists of sales of medical foods by entities (organizations, sole traders, and partnerships) that refer to foods, which are formulated to be administered or consumed under the presence of a physician, and it is intended to provide specific dietary management of a disease for which nutritional requirements are established by medical evaluation. Medical foods are exempt from the labelling requirements for nutrition content claims and health claims.

The main types of medical food include pill, powder, and others. The medical food pills refer to a small pellet or a tablet often coated and consumed by swallowing whole or by chewing. Medical food pills are specially formulated to meet nutritional requirements of patients with various medical conditions such as digression, ADHD, and others. They are used in treatment of Alzheimer's Disease, Diabetic Neuropathy, Nutritional Deficiency, ADHD, and others. They are sold through online, retail, and institutional channels.

North America was the largest region in the medical foods market in 2021. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical foods market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The medical foods market research report is one of a series of new reports from The Business Research Company that provides medical foods market statistics, including medical foods industry global market size, regional shares, competitors with a medical foods market share, detailed medical foods market segments, market trends and opportunities, and any further data you may need to thrive in the medical foods industry. This medical foods market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The increase in the geriatric population is significantly contributing to the growth of the medical foods market. At the molecular and cellular level, aging is caused by the accumulation of a range of biomolecular damage throughout time. This results in a gradual loss of functional capacity, as well as an increased risk of disease and eventually, death. These changes are not linear or continuous, and they have been only distantly related to a person's chronological age. As people get old, their dependency on certain nutritional foods increases especially medical foods to manage their health from chronic and age-related diseases. For instance, according to the US agency for international public health WHO, the global population aged 60 years and older will increase to 1.4 billion by 2030 from 1 billion in 2020. By 2050, the global population of adults aged 60 and up will have doubled (2.1 billion). Between 2020 and 2050, the number of people aged 80 and more is predicted to triple, reaching 426 million. Therefore, the increase in the geriatric population is expected to propel the growth of the medical foods market.

Constant innovations in product development is a key trend gaining popularity in the medical foods market. The companies operating in the medical foods sector are developing innovative products with greater efficacy to cater the demand from customers with specific niche diseases such as metabolic disorders, ADHD, and others. For instance, In February 2020, Galen US Inc., an Ireland-based pharmaceutical company launched PKU EASY Microtabs, a palatable alternative to protein substitutes, and it helps patients above 8 years to manage incurable condition "inherited metabolic disorder, phenylketonuria".

In September 2020, Nestle Health Science, a Swiss-based nutritional science company acquired IM HealthScience (IMH), along with its sister company, Physician's Seal (PS) for an undisclosed amount. With this acquisition, Nestle Health Science aims to strengthen its personalized medicine portfolio and the acquisition fits its mission of empowering healthier lives through nutrition. IM HealthScience (IMH) is a US-based firm that develops products to address overall health and wellness including medical foods.

The countries covered in the medical foods market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.